News

Gladstone in the News October 9, 2024

Nobel Winner Shinya Yamanaka: Cell Therapy Is ‘Very Promising’ For Cancer, Parkinson’s, More

Forbes—The world woke up 17 years ago to an astounding scientific breakthrough: a team of Japanese scientists led by Shinya Yamanaka—now an investigator at Gladstone—had reprogrammed skin cells to resemble an embryonic state. In this interview, Yamanaka shares fascinating insights about the backstory of his work and the doors it is starting to open for patients today.

Gladstone Experts Yamanaka Lab Stem Cells/iPSCs

Article February 8, 2024

Heart-to-Heart Connection: Exploratorium and Gladstone Bring a Breakthrough Science Exhibit to Life

At San Francisco’s Exploratorium, visitors sync their heartbeat with living heart cells; the first-of-its-kind exhibit was created through the museum’s long-running partnership with scientists at Gladstone Institutes.

News Release Stem Cells/iPSCs Conklin Lab Yamanaka Lab Cardiovascular Disease Research (Publication)

Article September 27, 2023

When Two Disruptive Technologies Converge

How gene editing and stem cells are working in tandem at Gladstone Institutes to change science and medicine

Deep Dive Stem Cells/iPSCs CRISPR/Gene Editing Srivastava Lab Yamanaka Lab Doudna Lab Conklin Lab Marson Lab Huang Lab Ott Lab

Article July 17, 2023

A Key Function for Tight Junctions in Embryo Models

Barriers between stem cells play a crucial role in human development—and offer a new potential route for fertility treatment

News Release Research (Publication) iPS Cell Research Center Yamanaka Lab Stem Cells/iPSCs

Gladstone in the News March 23, 2023

The Personalized Stem Cells That Could One Day Treat Parkinson’s and Heart Failure

The Wall Street Journal—Induced pluripotent stem cells have the potential to be used in innovative therapies for conditions like for Parkinson’s disease, macular degeneration, and heart failure. Gladstone Senior Investigator Shinya Yamanaka, who was the first to develop the technology, describes how a patient’s own cells can be used to generate tissue for transplantation.

Gladstone Experts Yamanaka Lab Stem Cells/iPSCs

Gladstone in the News November 3, 2022

Medical Milestones Are Underway at San Francisco’s Gladstone Institutes

Nob Hill Gazette—Home to 30 labs and 500 researchers, Gladstone is a hub of cutting-edge research and advances toward cures for the most devastating diseases.

Gladstone Experts Doudna Lab Greene Lab Ott Lab Srivastava Lab Weinberger Lab Yamanaka Lab Big Data CRISPR/Gene Editing Stem Cells/iPSCs

Gladstone in the News March 9, 2022

Disease in a Dish: What Mini-Hearts and Other Organs Reveal about Long COVID

San Jose Mercury News—Senior Investigators Melanie Ott, MD, PhD, and Bruce Conklin, MD, recount how they used miniature balls of beating heart cells called organoids to study the effects of COVID-19 on the heart. The heart cells were derived from a person's skin cells, thanks to technology pioneered by Senior Investigator and Nobel Laureate Shinya Yamanaka, MD, PhD.

Gladstone Experts Stem Cell Core COVID-19 Cardiovascular Disease Data Science and Biotechnology Virology Conklin Lab Ott Lab Yamanaka Lab Organoids

Article March 9, 2021

Building a Career in Science as a First-Generation College Student

Vanessa Arreola is a first-generation college student whose connection to Gladstone stems from high school

Research Associates Committee Profile Yamanaka Lab Diversity

Video January 20, 2021

The Convergence of CRISPR and Human Stem Cells

Gladstone President Deepak Srivastava moderated a conversation with Jennifer Doudna and Shinya Yamanaka.

Philanthropy Doudna Lab Yamanaka Lab CRISPR/Gene Editing Stem Cells/iPSCs

Gladstone in the News April 19, 2020

Nobel Laureate Yamanaka Frets over Japan’s Lax Coronavirus Fight

Nikkei Asian Review—Gladstone Senior Investigator Shinya Yamanaka is concerned about the spread of COVID-19 in Japan. To help keep people informed, he has begun a blog to share his scientific insights about the importance of social distancing and to shed light on how scientists are working to fight the virus.

Gladstone Experts COVID-19 Yamanaka Lab

Gladstone in the News March 22, 2020

Nobel Laureate Yamanaka Starts Website to Fight Coronavirus

The Asahi Shimbun—With the country in a state of socio-economic unrest, Gladstone Investigator Shinya Yamanaka launches his own website to expand the scope of knowledge surrounding the infectious pneumonia-like disease.

Gladstone Experts Yamanaka Lab

Article March 17, 2020

Meet Gladstone: Sam Perli

Sam Perli was going to be a computer scientist, but then he heard about engineering human cells with CRISPR technology, fell in love with biology, and never looked back.

Postdoctoral and Graduate Student Education and Research Development Affairs Graduate Students and Postdocs Profile Yamanaka Lab

Video February 17, 2020

Embracing Disruptive Technologies to Accelerate Science Overcoming Disease

From penicillin to organ transplants, so many important discoveries have dramatically changed healthcare and medicine over the past decades. But what’s really behind all this progress?

Gladstone Experts Research (Publication) Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab Yamanaka Lab

Article December 3, 2019

Gladstone Signs Agreement with Kyoto University for an On-site CiRA Laboratory

The Center for iPS Cell Research and Application (CiRA) at Kyoto University opened a new on-site laboratory at Gladstone Institutes.

Institutional News iPS Cell Research Center Yamanaka Lab Stem Cells/iPSCs

Article October 8, 2019

Connecting the Dots: From Stem Cells to Human Health

Since Shinya Yamanaka discovered a method to create human induced pluripotent stem (iPS) cells, Gladstone researchers have built on this technology to create numerous iPS cell lines, coax iPS cells into a myriad of tissue types, use them as a tool to study disease, and even begin creating therapies using these cells.

Research (Publication) Stem Cell Core Huntington’s Disease Alzheimer’s Disease Finkbeiner Lab Huang Lab McDevitt Lab Srivastava Lab Yamanaka Lab CRISPR/Gene Editing